EquityZen Growth Technology Fund LLC - Series 2473
Raised
$340K
Investors
20
Min Invest
$7,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2473 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on March 4, 2025. The vehicle raised $340K from 20 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $7K minimum investment. This is part of EquityZen's platform, which operates 150+ related EDGAR entities focused on private equity and late-stage growth company investments.
This offering falls within the typical range for EquityZen's series fund structure, using 506(b) private placement and 3(c)(1) investment company exemptions common to private equity vehicles. The $7K minimum represents a relatively accessible entry point compared to traditional private equity funds, consistent with EquityZen's model of fractionalizing access to pre-IPO company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
